Document Management For Pharmaceutical Teams

Last Updated: September 2026

What's the difference between a QMS and a document management system for pharma teams?

A pharmaceutical document management system (DMS) controls how regulated content — SOPs, batch records, protocols, submission documents — is created, approved, stored, and tracked, with the audit trails and e-signatures 21 CFR Part 11 requires. A quality management system (QMS) builds on that same document core, layering in the broader quality processes — CAPA, deviations, change control, risk management — that a DMS alone doesn't cover. Most pharmaceutical teams need both, increasingly from one connected platform rather than two separately-validated tools.

In this article:

• What is pharmaceutical document management, and why does it matter?
• How does document management support 21 CFR Part 11, GxP, and ISO requirements?
• What are the risks of paper-based or SharePoint-based systems?
• How can pharmaceutical companies ensure ALCOA+ data integrity?
• What features should a pharmaceutical document management system include?
• How do electronic systems streamline audits and inspections?
• What is the difference between a QMS and a document management system?
• How do companies validate a document management system?
• What are the cost considerations?
• Are there real-world examples of document management success?
• How Kivo Supports Pharmaceutical Document Management
• Frequently Asked Questions

Every pharmaceutical company lives and dies by its documentation.

Whether it is SOPs guiding daily operations, batch records capturing manufacturing runs, or regulatory submissions that determine product approval, documents are the connective tissue of compliance.

Yet, many teams are still stuck in outdated systems. Paper binders, SharePoint folders, and disconnected spreadsheets leave gaps that auditors can easily spot. A single missing signature or outdated version can stall an inspection, delay a launch, or trigger costly remediation.

Modern pharmaceutical document management is more than storage. It is a structured, validated environment that ensures every record is accurate, accessible, and inspection-ready.

For companies under constant regulatory scrutiny, document management is no longer optional. It is the backbone of quality, regulatory, and clinical operations.

The shift away from paper and general-purpose tools is already underway industry-wide: Fortune Business Insights values the global document management system market at $11.48 billion in 2026, up from $10.08 billion in 2025 — a 13.9% CAGR — as regulated industries move toward purpose-built, compliant platforms.

What is pharmaceutical document management, and why does it matter?

Pharmaceutical document management refers to the systems and processes that govern how regulated content is created, approved, stored, and tracked. This includes everything from SOPs and work instructions to clinical trial documents and regulatory submissions. At its core, document management ensures that every piece of information that supports product quality and patient safety is controlled and auditable.

The stakes are high.

Regulators want to see not only the documents themselves but also proof of how they were managed.

• Who approved the SOP?
• When was the last update made?
• How do you know this version is the most current? 

Without a robust system in place, answering these questions becomes a stressful scramble.

Effective document management changes the dynamic. It creates confidence that every document is complete, current, and compliant. Instead of fearing inspections, teams can focus on advancing programs, knowing their documentation will stand up to scrutiny.

How does document management support 21 CFR Part 11, GxP, and ISO requirements?

Compliance frameworks like 21 CFR Part 11, GxP, and ISO standards all demand the same thing: documented proof that processes are followed and data is trustworthy.

In practice, this means electronic signatures that are unique and verifiable, audit trails that record every change, and secure systems that prevent unauthorized access.

A well-designed document management system automates much of this heavy lifting:

• Audit trails are created in the background without user intervention.
• Electronic signatures are embedded into workflows, ensuring every approval step is captured and legally defensible.
• Version control guarantees that employees are always working from the most current document, while historical versions remain accessible for reference.

The result is a foundation that satisfies regulators and simplifies compliance. Instead of patching together manual records or scrambling to prove traceability, teams can demonstrate compliance by design. That shift reduces inspection risk and builds long-term credibility with regulatory bodies.

What are the risks of paper-based or SharePoint-based systems?

Many pharmaceutical teams still rely on paper files or general-purpose tools like SharePoint. While these approaches may seem inexpensive at first, they create significant long-term risks.

Paper files can be misplaced, damaged, or incomplete. SharePoint, while familiar, was not built for regulated environments. It lacks the built-in controls, validation support, and audit-ready features required for life sciences.

The risks show up during inspections. Missing metadata, inconsistent versioning, or unclear approval histories raise red flags for auditors. What starts as a quick inspection can escalate into findings, delays, or remediation costs.

The time and effort required to manually track updates or prove authenticity quickly outweighs the perceived savings of sticking with outdated tools. For a closer look at what a governed process should look like once a team moves off paper or SharePoint, see Kivo's guide to document control in life sciences.

When Elpida realized that continuing with a DIY system would lead to compliance delays on their life-saving mission, they worked with Kivo to build a flexible QMS that aligned with how their teams already operated. They were able to implement the system in just 3 weeks and on a crowdfunded budget, skipping the 6-12 month timeline of a legacy system rollout while added enterprise-grade compliance to their organization.

How can pharmaceutical companies ensure ALCOA+ data integrity?

ALCOA+ is the cornerstone of data integrity in life sciences. It stands for Attributable, Legible, Contemporaneous, Original, and Accurate, with the "+" expanding to include Complete, Consistent, Enduring, and Available. These principles ensure that records are not only correct but also trustworthy and reliable in the eyes of regulators.

Pharmaceutical document management systems make ALCOA+ achievable in practice. Each action within the system is attributable to a specific user, thanks to secure login and electronic signature requirements. Documents remain legible and unaltered, with changes tracked automatically in immutable audit trails. Updates are captured in real time, ensuring contemporaneous recordkeeping. Version control maintains original records while preserving complete histories.

By embedding these controls into daily workflows, companies can prove that their documentation meets ALCOA+ standards without added effort. Inspectors no longer need to take the team’s word for it. The system itself demonstrates compliance through its design, providing both peace of mind and regulatory confidence.

What features should a pharmaceutical document management system include?

Not all document management systems are built for regulated environments. Pharmaceutical teams require features that go beyond simple storage and sharing. At a minimum, a compliant system should include:

• Version control to ensure only the latest approved document is in use, with full access to prior versions.

• Automated audit trails that record every change, approval, and access attempt.

• Part 11 compliant electronic signatures to capture approvals in a secure and defensible way.

• Role-based access controls to ensure users can only view or edit what is appropriate for their role.

• Validation-ready infrastructure that supports both initial qualification and ongoing revalidation requirements.

• Integration with QMS and regulatory systems to eliminate silos and duplicate data entry.

These features transform documentation from a liability into a strategic asset. When built into everyday workflows, they reduce errors, strengthen compliance, and accelerate timelines.

How do electronic systems streamline audits and inspections?

Audits and inspections are some of the most stressful events for pharmaceutical teams. When documentation lives in binders or scattered file shares, preparing for an inspection means days or even weeks of collecting records, confirming versions, and cross-checking signatures. The pressure is immense, and the chance of missing something critical is high.

Electronic document management systems change the experience. With a single source of truth, teams can provide auditors with controlled access to records, confident that what they see is accurate and complete. Search functions make it easy to locate the right SOP or submission component in seconds. Audit trails prove who did what, when, without requiring additional explanation.

By streamlining audits and inspections, electronic systems not only reduce stress but also build confidence with regulators. Teams can demonstrate that compliance is built into their processes, not patched together at the last minute.

What is the difference between a QMS and a document management system?

The terms QMS and document management system are often used interchangeably, but they serve different purposes.

A document management system provides the foundation: it controls how documents are created, approved, stored, and tracked.

A QMS builds on that foundation by layering in processes like CAPA, change control, and risk management.

In other words, a DMS ensures documents are compliant and accessible, while a QMS ensures the broader quality processes are followed consistently. Both are essential, and in many organizations, they overlap significantly. For a closer look at evaluating QMS options specifically, see Kivo's guide to choosing a biotech QMS.

Modern platforms like Kivo combine the two. Instead of purchasing and validating separate tools, companies can use unified systems that integrate document control with quality workflows. This eliminates silos, reduces duplicate effort, and ensures that every process is tied back to a controlled document.

By having one environment power both, teams can move faster without sacrificing compliance.

How do companies validate a document management system?

Validation is one of the most important, and often most resource-intensive, aspects of adopting a document management system. Regulators expect proof that the system consistently performs as intended. This means documenting requirements, testing against those requirements, and maintaining evidence that the system remains in a validated state over time.

Traditional on-premise or highly customized systems make validation complex. Every upgrade can require extensive revalidation, consuming time and resources.

Cloud-based platforms reduce this burden by delivering pre-validated infrastructure and standardized updates that minimize disruption.

But historically, cloud-based systems in the life sciences industry have been unaffordable for today's small-to-midsized teams.

That's why  SSI Strategy partnered with Kivo to have us support their emerging biotech clients. Instead of wrestling with lengthy validation cycles or footing the bill for a legacy rollout, their clients now get immediately up and running with a fully validated and compliant system on a startup budget.

By choosing a platform that balances compliance with efficiency, companies can satisfy regulators without slowing innovation.

What are the cost considerations?

Cost is often the deciding factor when evaluating document management options. On the surface, spreadsheets or SharePoint may appear inexpensive. However, the hidden costs of inefficiency, remediation, and regulatory risk can far exceed the initial savings.

A single inspection finding tied to poor documentation control can result in costly delays and damage to reputation.

On the other end of the spectrum, legacy enterprise systems provide powerful functionality but come with high licensing fees, complex implementations, and significant ongoing maintenance costs. For many small to mid-sized pharmaceutical companies, these solutions feel out of reach.

This leaves a gap in the middle, where companies need enterprise-grade compliance at a cost that scales with their growth.

Purpose-built systems like Kivo are designed to fill this space.

We deliver the controls required by regulators without the overhead of traditional enterprise platforms. The result is affordable compliance that enables teams to focus resources on development and innovation rather than administration.

When evaluating cost, it is critical to consider more than license fees. Factor in validation effort, staff training, system updates, and the potential financial impact of non-compliance. The right document management system pays for itself by reducing risk, improving efficiency, and protecting the path to market.

Are there real-world examples of document management success?

Many pharmaceutical and biotech companies have seen the benefits of modern document management firsthand. By moving away from outdated tools, they have achieved faster submissions, smoother audits, and more efficient operations.

The right system enables teams to scale faster.

Like Hyloris, which doubled its programs in just two years by scaling regulatory, clinical, and quality operations with Kivo. Their team needed a solution that could keep pace with rapid growth without adding unnecessary complexity. By unifying document management with quality and regulatory functions, they were able to expand confidently while maintaining compliance.

The right system also reduces costs.

Like Elevar, which saved tens of thousands of dollars by moving  19 TMFs over to Kivo in just 72 days. Elevar's IT Director Matt W. noted, “The ease of use is so refreshing. The complexity of traditional Part 11 Compliant systems is nonsensical. They were designed by and for large organizations. But Kivo makes it so easy.”

These outcomes show that modern document management systems can be fully fledged businesses assets, providing value far beyond the compliance checklist. Teams running clinical trials alongside regulated documentation should also see how clinical document management integrates with eTMF.

How Kivo Supports Pharmaceutical Document Management

Kivo is a cloud-based, unified compliance platform for life sciences teams, combining a Part 11-compliant Document Management System (DMS) with Regulatory Information Management (RIM), electronic Trial Master File (eTMF), and Quality Management (QMS) — all built on one shared document core, so Regulatory, Clinical, Quality, and IT teams work out of the same controlled-content system instead of stitching several tools together. Kivo includes its own native, Part 11-compliant electronic signature with every subscription, at no additional charge, and ships continuous CSA-aligned validation with every release. Kivo is rated 4.9/5 on G2 and is used by 200+ sponsor, consultant, and CRO teams.

The following is not an independent ranking and doesn't assess implementation quality, market share, or fitness for any particular organization — evaluate any option against your own requirements.

All three are actively supporting life sciences document control today; which fits best depends on whether a team needs a single connected DMS/QMS/RIM/eTMF system, a quality-specific module inside a larger enterprise suite, or a content-governance layer added to existing storage. See Kivo's Document Management module for the full feature set.

If you'd like to see how Kivo can make your team more compliant, more efficient, and more effective, click below to speak with our team of life sciences veterans.

Frequently Asked Questions

Do I need a validated document management system if I'm pre-IND?
Yes — GxP document control requirements apply well before a first regulatory submission. Establishing SOPs, version control, and audit trails early avoids a costly retrofit once clinical or manufacturing activity begins.

Can SharePoint be made 21 CFR Part 11 compliant?
Not out of the box. SharePoint lacks native audit-trail immutability, Part 11 electronic signatures, and validation documentation — teams that try to retrofit compliance onto it typically spend more on configuration and maintenance than a purpose-built system costs.

What's the difference between document control and document management?
Document control is the governed process — approval, versioning, distribution, training — applied to controlled content. Document management is the broader system and infrastructure that makes document control possible at scale.

How long does it take to implement a compliant DMS?
Modern cloud-based, pre-validated platforms can go live in weeks; legacy enterprise systems that require custom validation projects often take six months or more.

Do electronic signatures need to come from a separate e-signature vendor?
No — a compliant DMS should include its own native, Part 11-validated electronic signature as part of the platform, rather than requiring a bolted-on third-party tool.